Financial Ratios Daxor Corporation NYSE

Stocks

DXR

US2394671034

Closed End Funds

Market Closed - NYSE 16:30:00 2026-09-18 EDT			5-day change	1st Jan Change
11.45 ^USD	-1.55%		-0.17%	-22.37%

08-31	Daxor Corporation Reports Earnings Results for the Half Year Ended June 30, 2026	CI
07-30	Daxor Launches Blood Testing Lab in Eastern Kansis	MT

3d15e32c0c2b18.Td82EfPqWScx6dz34dT3bc9tH903lBB7rxmfW7QxuSE.epZnKIqbK1d0mIqcjoayA4YXUIgP1kI22WPIGdIC7mcVuQdm3oYVcgenmQ

Published financial data: DAXOR CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Interest And Invest. Income (Rev)	278K	232K	163K	120K	26.69K
Total Revenues	278K	232K	163K	120K	26.69K
Gross Profit	278K	232K	163K	120K	26.69K
Selling General & Admin Expenses, Total	991K	1.09M	307K	294K	327K
Stock-Based Compensation (IS)	-	-	632K	1.25M	766K
Other Operating Expenses	32.36K	5.89K	12.4K	16.74K	16.29K
Other Operating Expenses, Total	1.02M	1.09M	951K	1.56M	1.11M
Operating Income	-746K	-860K	-788K	-1.44M	-1.08M
Interest Expense, Total	-19.6K	-72.45K	-49.1K	-85.09K	-15.96K
Net Interest Expenses	-19.6K	-72.45K	-49.1K	-85.09K	-15.96K
Other Non Operating Income (Expenses)	23.96K	-97.74K	33.77M	-1.65M	-293K
EBT, Excl. Unusual Items	-741K	-1.03M	32.94M	-3.17M	-1.39M
Gain (Loss) On Sale Of Investments	5.49M	6.21M	-32.66M	3.71M	10.56M
EBT, Incl. Unusual Items	4.75M	5.18M	281K	536K	9.17M
Income Tax Expense	-	-	-	-	-
Earnings From Continuing Operations	4.75M	5.18M	281K	536K	9.17M
Net Income to Company	4.75M	5.18M	281K	536K	9.17M
Net Income - (IS)	4.75M	5.18M	281K	536K	9.17M
Net Income to Common Incl Extra Items	4.75M	5.18M	281K	536K	9.17M
Net Income to Common Excl. Extra Items	4.75M	5.18M	281K	536K	9.17M
Per Share Items
Net EPS - Basic	1.18	1.21	0.06	0.11	1.81
Basic EPS - Continuing Operations	1.18	1.21	0.06	0.11	1.81
Basic Weighted Average Shares Outstanding	4.04M	4.29M	4.81M	4.93M	5.06M
Net EPS - Diluted	1.18	1.21	0.06	0.11	1.81
Diluted EPS - Continuing Operations	1.18	1.21	0.06	0.11	1.81
Diluted Weighted Average Shares Outstanding	4.04M	4.29M	4.81M	4.93M	5.06M
Normalized Basic EPS	-0.11	-0.15	4.28	-0.4	-0.17
Normalized Diluted EPS	-0.11	-0.15	4.28	-0.4	-0.17
Dividend Per Share	-	-	-	-	-
Payout Ratio	-	-	-	-	-
Supplemental Items
EBITA	-746K	-860K	-788K	-1.44M	-1.08M
EBIT	-746K	-860K	-788K	-1.44M	-1.08M
Total Revenues (As Reported)	278K	232K	163K	120K	26.69K
Effective Tax Rate - (Ratio)	-	-	-	-	-
Current Domestic Taxes	-	-	-	-	-
Current Foreign Taxes	-	-	-	-	-
Total Current Taxes	-	-	-	-	-
Normalized Net Income	-463K	-644K	20.59M	-1.98M	-870K
Supplemental Operating Expense Items
General and Administrative Expenses	991K	1.09M	307K	294K	327K
Stock-Based Comp., G&A Exp. (Total)	729K	787K	-	-	-
Stock-Based Comp., Other (Total)	-	-	632K	1.25M	766K
Total Stock-Based Compensation	729K	787K	632K	1.25M	766K

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Accounts Receivable, Total	30.7K	17.23K	14.2K	9.68K	-
Other Receivables	-	-	-	-	-
Total Receivables	30.7K	17.23K	14.2K	9.68K	-
Prepaid Expenses	23.1K	20.61K	11.68K	8.89K	9.86K
Restricted Cash	711K	-	-	-	-
Total Current Assets	764K	37.84K	25.88K	18.57K	9.86K
Long-term Investments	24.22M	30.22M	34.84M	36.61M	46M
Total Assets	24.98M	30.26M	34.87M	36.63M	46.01M
Liabilities
Accounts Payable, Total	87.4K	62.44K	103K	110K	112K
Short-term Borrowings	716K	-	-	-	-
Current Income Taxes Payable	-	-	-	-	10.6K
Other Current Liabilities	3.22K	-	-	-	-
Total Current Liabilities	806K	62.44K	103K	110K	123K
Long-Term Debt	3.02M	1.23M	756K	730K	-
Total Liabilities	3.83M	1.29M	859K	840K	123K
Common Stock, Total	53.17K	53.17K	53.17K	54.09K	55.35K
Additional Paid In Capital	12.11M	12.9M	13.69M	14.61M	15.53M
Retained Earnings	19.61M	24.79M	25.09M	25.63M	34.8M
Treasury Stock	-10.62M	-8.77M	-4.83M	-4.5M	-4.5M
Total Common Equity	21.15M	28.97M	34.01M	35.79M	45.89M
Total Equity	21.15M	28.97M	34.01M	35.79M	45.89M
Total Liabilities And Equity	24.98M	30.26M	34.87M	36.63M	46.01M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	4.04M	4.29M	4.81M	4.93M	5.06M
ECS Total Common Shares Outstanding	4.04M	4.29M	4.81M	4.93M	5.06M
Book Value / Share	5.24	6.75	7.08	7.25	9.07
Tangible Book Value	21.15M	28.97M	34.01M	35.79M	45.89M
Tangible Book Value Per Share	5.24	6.75	7.08	7.25	9.07
Total Debt	3.74M	1.23M	756K	730K	0
Net Debt	3.74M	1.23M	756K	730K	-
Account Code - Inventory Valuation	3	-	3	3	3

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	4.75M	5.18M	281K	536K	9.17M
(Gain) Loss on Sale of Investments - (CF)	-5.49M	-6.21M	-1.17M	-2.1M	-10.56M
Stock-Based Compensation (CF)	729K	787K	632K	1.25M	766K
Other Operating Activities, Total	-2.96M	-517K	-3.45M	326K	1.18M
Change In Accounts Receivable	-1.4K	13.47K	3.04K	4.52K	9.7K
Change In Accounts Payable	7.4K	-	-	-	-
Change In Income Taxes	-	-	-	-	-
Change In Deferred Taxes	211K	-	-	-	-
Change in Other Net Operating Assets	-	-22.47K	49.59K	9.57K	11.53K
Cash from Operations	-2.76M	-769K	-3.66M	25.69K	571K
Long-Term Debt Issued, Total	3.71M	4.08M	4.11M	2.03M	692K
Total Debt Issued	3.71M	4.08M	4.11M	2.03M	692K
Long-Term Debt Repaid, Total	-857K	-5.87M	-4.59M	-2.05M	-1.42M
Total Debt Repaid	-857K	-5.87M	-4.59M	-2.05M	-1.42M
Issuance of Common Stock	-	1.85M	4.53M	-	159K
Repurchase of Common Stock	-	-	-401K	-	-
Common Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Cash from Financing	2.85M	58.6K	3.66M	-25.69K	-571K
Net Change in Cash	92.9K	-711K	-	-	-
Supplemental Items
Cash Interest Paid	19.6K	72.45K	49.1K	85.09K	15.96K
Cash Income Tax Paid (Refund)	30.39K	9.71K	13.8K	3.48K	4.4K
Levered Free Cash Flow	378K	902K	161K	309K	100K
Unlevered Free Cash Flow	390K	948K	192K	362K	110K
Change In Net Working Capital	-127K	-698K	-52.62K	-14.54K	-20.97K
Net Debt Issued / Repaid	2.85M	-1.79M	-474K	-25.69K	-730K

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	-2.24	-1.95	-1.51	-2.51	-1.64
Return on Total Capital	-2.25	-1.95	-1.52	-2.52	-1.64
Return On Equity %	25.79	20.66	0.89	1.54	22.45
Return on Common Equity	25.79	20.66	0.89	1.54	22.45
Margin Analysis
Gross Profit Margin %	100	100	100	100	100
SG&A Margin	356.47	468.61	188.08	245.74	1.23K
EBITA Margin %	-268.11	-371.15	-482.21	-1.2K	-4.06K
EBIT Margin %	-268.11	-371.15	-482.21	-1.2K	-4.06K
Income From Continuing Operations Margin %	1.71K	2.24K	171.73	448.01	34.36K
Net Income Margin %	1.71K	2.24K	171.73	448.01	34.36K
Net Avail. For Common Margin %	1.71K	2.24K	171.73	448.01	34.36K
Normalized Net Income Margin	-166.59	-277.89	12.6K	-1.66K	-3.26K
Levered Free Cash Flow Margin	136	389.61	98.58	258.07	375.63
Unlevered Free Cash Flow Margin	140.41	409.16	117.36	302.5	413.01
Asset Turnover
Asset Turnover	0.01	0.01	0.01	0	0
Short Term Liquidity
Current Ratio	0.95	0.61	0.25	0.17	0.08
Quick Ratio	0.04	0.28	0.14	0.09	-
Operating Cash Flow to Current Liabilities	-3.42	-12.32	-35.45	0.23	4.66
Long Term Solvency
Total Debt/Equity	17.67	4.24	2.22	2.04	-
Total Debt / Total Capital	15.02	4.07	2.17	2	-
LT Debt/Equity	14.29	4.24	2.22	2.04	-
Long-Term Debt / Total Capital	12.14	4.07	2.17	2	-
Total Liabilities / Total Assets	15.33	4.27	2.46	2.29	0.27
EBIT / Interest Expense	-38.03	-11.87	-16.05	-16.89	-67.82
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	5.16	-16.7	-29.45	-26.75	-77.71
Gross Profit, 1 Yr. Growth %	5.16	-16.7	-29.45	-26.75	-77.71
EBITA, 1 Yr. Growth %	120.62	15.31	-8.34	82.32	-24.65
EBIT, 1 Yr. Growth %	120.62	15.31	-8.34	82.32	-24.65
Earnings From Cont. Operations, 1 Yr. Growth %	-378.42	9.05	-94.58	91.11	1.61K
Net Income, 1 Yr. Growth %	-378.42	9.05	-94.58	91.11	1.61K
Normalized Net Income, 1 Yr. Growth %	-346.62	38.95	-3.3K	-109.64	-56.16
Diluted EPS Before Extra, 1 Yr. Growth %	-378.07	2.65	-95.16	86.16	1.57K
Accounts Receivable, 1 Yr. Growth %	4.79	-43.87	-17.61	-31.84	-
Total Assets, 1 Yr. Growth %	50.92	21.13	15.23	5.06	25.6
Tangible Book Value, 1 Yr. Growth %	34.94	36.95	17.4	5.24	28.2
Common Equity, 1 Yr. Growth %	34.94	36.95	17.4	5.24	28.2
Cash From Operations, 1 Yr. Growth %	12.72	-72.12	375.12	-100.7	2.12K
Levered Free Cash Flow, 1 Yr. Growth %	-175.42	138.62	-82.15	91.77	-67.55
Unlevered Free Cash Flow, 1 Yr. Growth %	-178.69	142.73	-79.76	88.81	-69.56
Dividend Per Share, 1 Yr. Growth %	-	-	-	-	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-14.47	-6.41	-23.34	-28.11	-59.59
Gross Profit, 2 Yr. CAGR %	-14.47	-6.41	-23.34	-28.11	-59.59
EBITA, 2 Yr. CAGR %	489.7	59.5	2.81	29.28	17.21
EBIT, 2 Yr. CAGR %	489.7	59.5	2.81	29.28	17.21
Earnings From Cont. Operations, 2 Yr. CAGR %	209.5	74.25	-75.69	-67.82	471.62
Net Income, 2 Yr. CAGR %	209.5	74.25	-75.69	-67.82	471.62
Normalized Net Income, 2 Yr. CAGR %	164.66	85.12	566.61	75.56	-79.45
Diluted EPS Before Extra, 2 Yr. CAGR %	198.09	68.95	-77.71	-69.99	457.13
Accounts Receivable, 2 Yr. CAGR %	-3.16	-23.31	-31.99	-25.06	-
Total Assets, 2 Yr. CAGR %	32.63	35.21	18.14	10.02	14.87
Tangible Book Value, 2 Yr. CAGR %	28.72	35.95	26.8	11.15	16.16
Common Equity, 2 Yr. CAGR %	28.72	35.95	26.8	11.15	16.16
Cash From Operations, 2 Yr. CAGR %	-5.84	-43.94	15.1	-81.73	-60.48
Levered Free Cash Flow, 2 Yr. CAGR %	19.35	34.15	-34.73	-41.49	-21.12
Unlevered Free Cash Flow, 2 Yr. CAGR %	4.84	38.2	-29.92	-38.19	-24.19
Dividend Per Share, 2 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-13.52	-15.22	-14.82	-24.49	-51.34
Gross Profit, 3 Yr. CAGR %	-13.52	-15.22	-14.82	-24.49	-51.34
EBITA, 3 Yr. CAGR %	62.67	242.28	32.61	24.44	7.99
EBIT, 3 Yr. CAGR %	62.67	242.28	32.61	24.44	7.99
Earnings From Cont. Operations, 3 Yr. CAGR %	75.01	118.6	-45.2	-51.66	20.98
Net Income, 3 Yr. CAGR %	75.01	118.6	-45.2	-51.66	20.98
Normalized Net Income, 3 Yr. CAGR %	96.84	113.5	378.55	62.4	10.55
Diluted EPS Before Extra, 3 Yr. CAGR %	70.69	108.94	-48.31	-54.78	14.52
Accounts Receivable, 3 Yr. CAGR %	-3.07	-19.26	-21.45	-31.94	-
Total Assets, 3 Yr. CAGR %	12.33	28.68	28.19	13.61	14.99
Tangible Book Value, 3 Yr. CAGR %	17.43	31.41	29.46	19.16	16.57
Common Equity, 3 Yr. CAGR %	17.43	31.41	29.46	19.16	16.57
Cash From Operations, 3 Yr. CAGR %	28	-37.24	14.3	-78.96	-9.46
Levered Free Cash Flow, 3 Yr. CAGR %	-24.62	50.35	-31.51	-6.52	-51.93
Unlevered Free Cash Flow, 3 Yr. CAGR %	-25.88	38.7	-27.16	-2.48	-51.19
Dividend Per Share, 3 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-12.22	-15.93	-17.59	-20.63	-36.79
Gross Profit, 5 Yr. CAGR %	-12.22	-15.93	-17.59	-20.63	-36.79
EBITA, 5 Yr. CAGR %	26.66	15.03	35.39	131.86	26.22
EBIT, 5 Yr. CAGR %	26.66	15.03	35.39	131.86	26.22
Earnings From Cont. Operations, 5 Yr. CAGR %	26.67	33.09	-20.54	1.59	39.99
Net Income, 5 Yr. CAGR %	26.67	33.09	-20.54	1.59	39.99
Normalized Net Income, 5 Yr. CAGR %	13.21	10.8	220.64	97.43	35.87
Diluted EPS Before Extra, 5 Yr. CAGR %	25.13	29.46	-24.4	-3.85	33.79
Accounts Receivable, 5 Yr. CAGR %	-7.72	-17.56	-15.88	-21.63	-
Total Assets, 5 Yr. CAGR %	3.91	9.4	14.62	20.87	22.69
Tangible Book Value, 5 Yr. CAGR %	6.63	16.06	21.09	22.9	23.96
Common Equity, 5 Yr. CAGR %	6.63	16.06	21.09	22.9	23.96
Cash From Operations, 5 Yr. CAGR %	11.62	-8.08	22.67	-61.69	-25.26
Levered Free Cash Flow, 5 Yr. CAGR %	26.42	-10.19	-28.84	3.07	-27.53
Unlevered Free Cash Flow, 5 Yr. CAGR %	22.69	-9.84	-27.52	0.39	-25.99
Dividend Per Share, 5 Yr. CAGR %	-	-	-	-	-